London [UK]/Mumbai (Maharashtra) [India], March 11 (ANI/PRNewswire): Datar Cancer Genetics, a global leader in non-invasive cancer diagnostics, has received Conformite Europeenne (CE) Mark for its innovative TruBlood solution, a new paradigm in cancer detection, diagnosis and management.
London [UK], November 9 (ANI/PRNewswire): A large, landmark study published in the American Cancer Society's prestigious journal 'Cancer Cytopathology' shows that a simple non-invasive blood test (liquid biopsy) can accurately differentiate between non-cancerous tumors versus cancerous gr
Mumbai (Maharashtra) [India] September 29 (ANI/PRNewswire): A landmark study published in the American Association of Cancer Research's (AACR) prestigious journal 'Cancer Prevention Research' has shown that it is possible to identify healthy individuals with a higher risk of cancer based on
Washington D.C. [USA], Jan 19 (ANI): While several health studies have indicated that men are at a higher risk of developing cancer as compared to women, a recent study finds the reason behind higher susceptibility towards this deadly disease. The study has pinpointed the loss of function in
Barcelona [Spain], Jan 17 (ANI): Several studies have indicated that men are more prone to developing cancer as compared to women, however very little is known about why they display a higher susceptibility towards this deadly disease.
Mumbai [India], Jan 12 (ANI-BusinessWireIndia): Datar Cancer Genetics Limited, a leading molecular and genetic analysis company has been awarded accreditation by the Accreditation Committee of the College of American Pathologists (CAP), post a recent on-site inspection and audit.
Mumbai [India], Oct 13 (ANI-BusinessWireIndia): Early detection of cancer has been the Holy Grail for scientists all over the world. Late stage detection is one of the primary reasons for death in cancer patients.